Nrf2 is required for normal postnatal bone acquisition in mice

Jung Hyun Kim, Vandana Singhal, Shyam Biswal, Rajesh K. Thimmulappa, Douglas DiGirolamo

Research output: Contribution to journalArticle

Abstract

A large body of literature suggests that bone metabolism is susceptible to the ill effects of reactive species that accumulate in the body and cause cellular dysfunction. One of the body's front lines in defense against such damage is the transcription factor, Nrf2. This transcription factor regulates a plethora of antioxidant and cellular defense pathways to protect cells from such damage. Despite the breadth of knowledge of both the function of Nrf2 and the effects of reactive species in bone metabolism, the direct role of Nrf2 in skeletal biology has yet to be thoroughly examined. Thus, in the current study, we have examined the role of Nrf2 in postnatal bone metabolism in mice. Mice lacking Nrf2 (Nrf2-/-) exhibited a marked deficit in postnatal bone acquisition, which was most severe at 3 weeks of age when osteoblast numbers were 12-fold less than observed in control animals. While primary osteoblasts from Nrf2-/- mice functioned normally in vitro, the colony forming capacity of bone marrow stromal cells (BMSCs) from these mice was significantly reduced compared to controls. This defect could be rescued through treatment with the radical scavenger N-acetyl cysteine (NAC), suggesting that increased reactive species stress might impair early osteoblastogenesis in BMSCs and lead to the failure of bone acquisition observed in Nrf2-/- animals. Taken together, these studies suggest Nrf2 represents a key pathway in regulating bone metabolism, which may provide future therapeutic targets to treat osteoporosis.

Original languageEnglish (US)
Article number14033
JournalBone Research
Volume2
DOIs
StatePublished - 2015

Fingerprint

Bone and Bones
Osteoblasts
Mesenchymal Stromal Cells
Transcription Factors
Osteoporosis
Cysteine
Antioxidants
Therapeutics

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Histology
  • Physiology

Cite this

Nrf2 is required for normal postnatal bone acquisition in mice. / Kim, Jung Hyun; Singhal, Vandana; Biswal, Shyam; Thimmulappa, Rajesh K.; DiGirolamo, Douglas.

In: Bone Research, Vol. 2, 14033, 2015.

Research output: Contribution to journalArticle

Kim, Jung Hyun ; Singhal, Vandana ; Biswal, Shyam ; Thimmulappa, Rajesh K. ; DiGirolamo, Douglas. / Nrf2 is required for normal postnatal bone acquisition in mice. In: Bone Research. 2015 ; Vol. 2.
@article{94af502118cf499fa67d86deaca4e2ef,
title = "Nrf2 is required for normal postnatal bone acquisition in mice",
abstract = "A large body of literature suggests that bone metabolism is susceptible to the ill effects of reactive species that accumulate in the body and cause cellular dysfunction. One of the body's front lines in defense against such damage is the transcription factor, Nrf2. This transcription factor regulates a plethora of antioxidant and cellular defense pathways to protect cells from such damage. Despite the breadth of knowledge of both the function of Nrf2 and the effects of reactive species in bone metabolism, the direct role of Nrf2 in skeletal biology has yet to be thoroughly examined. Thus, in the current study, we have examined the role of Nrf2 in postnatal bone metabolism in mice. Mice lacking Nrf2 (Nrf2-/-) exhibited a marked deficit in postnatal bone acquisition, which was most severe at 3 weeks of age when osteoblast numbers were 12-fold less than observed in control animals. While primary osteoblasts from Nrf2-/- mice functioned normally in vitro, the colony forming capacity of bone marrow stromal cells (BMSCs) from these mice was significantly reduced compared to controls. This defect could be rescued through treatment with the radical scavenger N-acetyl cysteine (NAC), suggesting that increased reactive species stress might impair early osteoblastogenesis in BMSCs and lead to the failure of bone acquisition observed in Nrf2-/- animals. Taken together, these studies suggest Nrf2 represents a key pathway in regulating bone metabolism, which may provide future therapeutic targets to treat osteoporosis.",
author = "Kim, {Jung Hyun} and Vandana Singhal and Shyam Biswal and Thimmulappa, {Rajesh K.} and Douglas DiGirolamo",
year = "2015",
doi = "10.1038/boneres.2014.33",
language = "English (US)",
volume = "2",
journal = "Bone Research",
issn = "2095-4700",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Nrf2 is required for normal postnatal bone acquisition in mice

AU - Kim, Jung Hyun

AU - Singhal, Vandana

AU - Biswal, Shyam

AU - Thimmulappa, Rajesh K.

AU - DiGirolamo, Douglas

PY - 2015

Y1 - 2015

N2 - A large body of literature suggests that bone metabolism is susceptible to the ill effects of reactive species that accumulate in the body and cause cellular dysfunction. One of the body's front lines in defense against such damage is the transcription factor, Nrf2. This transcription factor regulates a plethora of antioxidant and cellular defense pathways to protect cells from such damage. Despite the breadth of knowledge of both the function of Nrf2 and the effects of reactive species in bone metabolism, the direct role of Nrf2 in skeletal biology has yet to be thoroughly examined. Thus, in the current study, we have examined the role of Nrf2 in postnatal bone metabolism in mice. Mice lacking Nrf2 (Nrf2-/-) exhibited a marked deficit in postnatal bone acquisition, which was most severe at 3 weeks of age when osteoblast numbers were 12-fold less than observed in control animals. While primary osteoblasts from Nrf2-/- mice functioned normally in vitro, the colony forming capacity of bone marrow stromal cells (BMSCs) from these mice was significantly reduced compared to controls. This defect could be rescued through treatment with the radical scavenger N-acetyl cysteine (NAC), suggesting that increased reactive species stress might impair early osteoblastogenesis in BMSCs and lead to the failure of bone acquisition observed in Nrf2-/- animals. Taken together, these studies suggest Nrf2 represents a key pathway in regulating bone metabolism, which may provide future therapeutic targets to treat osteoporosis.

AB - A large body of literature suggests that bone metabolism is susceptible to the ill effects of reactive species that accumulate in the body and cause cellular dysfunction. One of the body's front lines in defense against such damage is the transcription factor, Nrf2. This transcription factor regulates a plethora of antioxidant and cellular defense pathways to protect cells from such damage. Despite the breadth of knowledge of both the function of Nrf2 and the effects of reactive species in bone metabolism, the direct role of Nrf2 in skeletal biology has yet to be thoroughly examined. Thus, in the current study, we have examined the role of Nrf2 in postnatal bone metabolism in mice. Mice lacking Nrf2 (Nrf2-/-) exhibited a marked deficit in postnatal bone acquisition, which was most severe at 3 weeks of age when osteoblast numbers were 12-fold less than observed in control animals. While primary osteoblasts from Nrf2-/- mice functioned normally in vitro, the colony forming capacity of bone marrow stromal cells (BMSCs) from these mice was significantly reduced compared to controls. This defect could be rescued through treatment with the radical scavenger N-acetyl cysteine (NAC), suggesting that increased reactive species stress might impair early osteoblastogenesis in BMSCs and lead to the failure of bone acquisition observed in Nrf2-/- animals. Taken together, these studies suggest Nrf2 represents a key pathway in regulating bone metabolism, which may provide future therapeutic targets to treat osteoporosis.

UR - http://www.scopus.com/inward/record.url?scp=84934976747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934976747&partnerID=8YFLogxK

U2 - 10.1038/boneres.2014.33

DO - 10.1038/boneres.2014.33

M3 - Article

C2 - 26273528

AN - SCOPUS:84934976747

VL - 2

JO - Bone Research

JF - Bone Research

SN - 2095-4700

M1 - 14033

ER -